Biologics Contract Development Market Report 2030: Key Insights You Need to Know

According to the study by Next Move Strategy Consulting, the global Biologics Contract Development Market size is predicted to reach USD 13.84 billion with a CAGR of 8.8% by 2030.

Request a FREE Sample: https://www.nextmsc.com/biologics-contract-development-market/request-sample

The rising cases of chronic diseases such as cancer, autoimmune disorders, diabetes, and cardiovascular diseases across the globe is increasing the biologics contract development market demand.

North-America dominates the biologics contract development market share and is expected to continue its dominance during the forecast period.

The biologics contract development industry comprises various key players such as AGC Biologics, Boehringer Ingelheim, Catalent, Cell Therapies, WuXi Biologics, FUJIFILM Diosynth Biotechnologies, KBI Biopharma, Kemwell Biopharma, Lonza, Samsung Biologics, and others.